Wednesday, July 8, 2026

biotech · Melanoma · Psoriasis · PVCT

Provectus Biopharmaceuticals

Provectus Biopharmaceuticals is a biotech organization headquartered in Knoxville, USA. It trades on NYSE under ticker PVCT. Primary therapeutic focus areas include Melanoma, Psoriasis, Atopic Dermatitis, Plaque Psoriasi

Knoxville, Tennessee 37932, US HQ
2004 Founded
7 Employees
Public company Type
PVCT · NYSE Ticker
Company details
Status
Public
HQ
Knoxville, Tennessee 37932, US
Founded
2004
Employees
7
Programs
12
Drugs
5
Patents
29
Clinical program

Rose bengal disodium

Phase 1 · small molecule · Neuroendocrine Tumors Metastatic to the Liver

Rose bengal disodium for Neuroendocrine Tumors Metastatic to the Liver is a Phase 1 program (small_molecule) at PROVECTUS BIOPHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Internal code PV-10-NET-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
PROVECTUS BIOPHARMACEUTICALS, INC.
Phase
Phase 1
Modality
small_molecule
Indication
Neuroendocrine Tumors Metastatic to the Liver
Status
active
Trials
1